BCM
Bayesian Capital Management’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-65,900
| Closed | -$145K | – | 717 |
|
|
2024
Q4 | $145K | Buy |
+65,900
| New | +$145K | 0.02% | 596 |
|
|
2024
Q2 | – | Sell |
-51,200
| Closed | -$137K | – | 847 |
|
|
2024
Q1 | $137K | Buy |
+51,200
| New | +$137K | 0.01% | 693 |
|
|
2023
Q4 | – | Sell |
-17,600
| Closed | -$17.2K | – | 834 |
|
|
2023
Q3 | $17.2K | Buy |
+17,600
| New | +$17.2K | ﹤0.01% | 655 |
|
|
2022
Q4 | – | Sell |
-27,630
| Closed | -$185K | – | 849 |
|
|
2022
Q3 | $185K | Buy |
+27,630
| New | +$185K | 0.04% | 532 |
|
|
2022
Q2 | – | Sell |
-29,795
| Closed | -$138K | – | 863 |
|
|
2022
Q1 | $138K | Buy |
+29,795
| New | +$138K | 0.02% | 679 |
|
|
2018
Q2 | – | Sell |
-3,199
| Closed | -$231K | – | 638 |
|
|
2018
Q1 | $231K | Buy |
+3,199
| New | +$231K | 0.06% | 463 |
|
|
2017
Q4 | – | Sell |
-11,127
| Closed | -$558K | – | 592 |
|
|
2017
Q3 | $558K | Buy |
+11,127
| New | +$558K | 0.13% | 247 |
|